Literature DB >> 15505133

International normalized ratio increase before warfarin-associated hemorrhage: brief and subtle.

Nils Kucher1, Shannon Connolly, Joshua A Beckman, Lay Har Cheng, Kanella V Tsilimingras, John Fanikos, Samuel Z Goldhaber.   

Abstract

OBJECTIVE: To determine the relationship between serial international normalized ratios (INRs) in patients who have been undergoing long-term anticoagulation and the onset of warfarin-associated bleeding complications.
METHODS: The study cohort consisted of 2391 patients treated in the Anticoagulation Service at Brigham and Women's Hospital, Boston, Mass, from April 1999 through July 2003. For each patient with a bleeding event, we selected 2 controls who were matched for age, sex, indication for warfarin therapy, and duration of enrollment in our Anticoagulation Service.
RESULTS: Warfarin-related hemorrhage occurred in 32 patients (1.3%). The mean +/- SD INRs at the time of the bleeding event or matched patient's event date (5.9 +/- 5.9 vs 2.3 +/- 0.7; P<.001) and the mean+/-SD last INRs before the bleeding event or matched patient's event date (3.0 +/- 1.2 vs 2.1 +/- 0.8; P<.001) were higher in the patients than in the controls. The last INRs before the bleeding event were obtained an average of 11.6 +/- 17.8 (mean +/- SD) days before the event in the patients and 18.3 +/- 28.0 (mean +/- SD) days before the matched date in the controls (P = .22). The mean second-to-last INRs were similar in both groups (2.8 +/- 2.1 vs 2.3 +/- 0.8; P = .11). When the INRs were plotted in relation to the time before the onset of bleeding, a marked increase in the patients' INRs was observed shortly before the bleeding began.
CONCLUSIONS: Serial INRs are poor predictors of hemorrhagic events. There appears to be only a brief warning period during which a slightly elevated INR predicts an imminent bleeding event.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15505133     DOI: 10.1001/archinte.164.19.2176

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

1.  A prospective analysis of the preventability of adverse drug reactions reported in Sweden.

Authors:  Henrik Lövborg; Linda Ring Eriksson; Anna K Jönsson; Thomas Bradley; Staffan Hägg
Journal:  Eur J Clin Pharmacol       Date:  2012-02-19       Impact factor: 2.953

2.  Adverse interaction of warfarin and paracetamol: evidence from a post-mortem study.

Authors:  Terhi Launiainen; Antti Sajantila; Ilpo Rasanen; Erkki Vuori; Ilkka Ojanperä
Journal:  Eur J Clin Pharmacol       Date:  2009-09-25       Impact factor: 2.953

3.  Complication of warfarin therapy presenting as empyema.

Authors:  Paresh Kumar Kuba; Jasvinder Sharma; Ashok K Sharma
Journal:  J Thorac Dis       Date:  2011-03       Impact factor: 2.895

4.  Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinics.

Authors:  Jonas Wallvik; Anders Själander; Lars Johansson; Orjan Bjuhr; Jan-Håkan Jansson
Journal:  Scand J Prim Health Care       Date:  2007-06       Impact factor: 2.581

5.  Bleeding events and associated factors in a cohort of adult patients taking warfarin in Sarawak, Malaysia.

Authors:  Frances Edwards; Paul Arkell; Lesley M Roberts; David Gendy; Christina Siew-Hie Wong; Joanna Chee Yien Ngu; Lee Len Tiong; Faridha Mohd Salleh Bibi; Lana Yin Hui Lai; Tiong Kiam Ong; Michael Abouyannis
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.